Analyses of Existing Framingham Data
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00342810|
Recruitment Status : Completed
First Posted : June 21, 2006
Last Update Posted : December 17, 2019
Since 1948, the Framingham Study has examined a group of men and women every two years for the primary purpose of studying the incidence and prevalence of cardiovascular disease and its risk factors. In 1971 the Framingham Study began a study of the offspring of the original group, including data collection on blood pressure, cigarette smoking, weight, and other factors that are of interest to studies of eye disease. Researchers gave eye exams to some of the original group and to the offspring group. Data from these eye exams have been used to examine risk factors for cataracts, diabetic retinopathy, myopia, and glaucoma.
The purpose of this study is to use the previously collected data for continued research on eye-related disorders. No new eye examinations will be conducted.
|Condition or disease|
|Study Type :||Observational|
|Actual Enrollment :||6061 participants|
|Official Title:||Continued Analyses of Epidemiologic Risk Factors Using Existing Framingham Eye and Heart Study Data|
|Study Start Date :||June 25, 2003|
|Study Completion Date :||April 25, 2018|
- Explore associations using study data [ Time Frame: Continuous ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00342810
|United States, Maryland|
|National Eye Institute (NEI), 9000 Rockville Pike|
|Bethesda, Maryland, United States, 20892|
|Principal Investigator:||Susan Vitale, Ph.D.||National Eye Institute (NEI)|